BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30830383)

  • 1. Analysis of metabolites and metabolic pathways in breast cancer in a Korean prospective cohort: the Korean Cancer Prevention Study-II.
    Yoo HJ; Kim M; Kim M; Kang M; Jung KJ; Hwang SM; Jee SH; Lee JH
    Metabolomics; 2018 Jun; 14(6):85. PubMed ID: 30830383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics Profiles of Hepatocellular Carcinoma in a Korean Prospective Cohort: The Korean Cancer Prevention Study-II.
    Jee SH; Kim M; Kim M; Yoo HJ; Kim H; Jung KJ; Hong S; Lee JH
    Cancer Prev Res (Phila); 2018 May; 11(5):303-312. PubMed ID: 29500188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer detection using targeted plasma metabolomics.
    Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
    Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
    Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine, glutamic acid and ethylmalonic acid as important metabolites for detecting human breast cancer based on the targeted metabolomics.
    Wang X; Zhao X; Chou J; Yu J; Yang T; Liu L; Zhang F
    Cancer Biomark; 2018; 23(2):255-268. PubMed ID: 30103303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic fingerprinting in breast cancer stages through
    Suman S; Sharma RK; Kumar V; Sinha N; Shukla Y
    J Pharm Biomed Anal; 2018 Oct; 160():38-45. PubMed ID: 30059813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Cirrhosis Patients Who Had Normal Liver Function Before Liver Cirrhosis Development Have the Altered Metabolic Profiles Before the Disease Occurrence Compared to Healthy Controls.
    Yoo HJ; Jung KJ; Kim M; Kim M; Kang M; Jee SH; Choi Y; Lee JH
    Front Physiol; 2019; 10():1421. PubMed ID: 31803070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Potential Biomarkers and Metabolic Profiling of Serum in Ovarian Cancer Patients Using UPLC/Q-TOF MS.
    Yang W; Mu T; Jiang J; Sun Q; Hou X; Sun Y; Zhong L; Wang C; Sun C
    Cell Physiol Biochem; 2018; 51(3):1134-1148. PubMed ID: 30476914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS/MS platform-based serum untargeted screening reveals the diagnostic biomarker panel and molecular mechanism of breast cancer.
    Gong S; Wang Q; Huang J; Huang R; Chen S; Cheng X; Liu L; Dai X; Zhong Y; Fan C; Liao Z
    Methods; 2024 Feb; 222():100-111. PubMed ID: 38228196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
    Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
    J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
    Wu N; Wang W; Yi M; Cheng S; Wang D
    Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort.
    Lécuyer L; Dalle C; Lyan B; Demidem A; Rossary A; Vasson MP; Petera M; Lagree M; Ferreira T; Centeno D; Galan P; Hercberg S; Deschasaux M; Partula V; Srour B; Latino-Martel P; Kesse-Guyot E; Druesne-Pecollo N; Durand S; Pujos-Guillot E; Touvier M
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1300-1307. PubMed ID: 31164347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
    He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
    Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
    Shang X; Zhong X; Tian X
    Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of altered urinary metabolomic profiles of invasive ductal carcinoma of breast using targeted and untargeted approaches.
    More TH; Taware R; Taunk K; Chanukuppa V; Naik V; Mane A; Rapole S
    Metabolomics; 2018 Aug; 14(8):107. PubMed ID: 30830381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of serum metabolomics in women with breast Cancer Prior to Chemotherapy and at 1 year: cardiometabolic implications.
    Lyon DE; Yao Y; Garrett T; Kelly DL; Cousin L; Archer KJ
    BMC Womens Health; 2023 May; 23(1):221. PubMed ID: 37138260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry.
    Wang D; Tan G; Wang H; Chen P; Hao J; Wang Y
    J Pharm Biomed Anal; 2019 Mar; 166():357-363. PubMed ID: 30690249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study.
    Stepien M; Keski-Rahkonen P; Kiss A; Robinot N; Duarte-Salles T; Murphy N; Perlemuter G; Viallon V; Tjønneland A; Rostgaard-Hansen AL; Dahm CC; Overvad K; Boutron-Ruault MC; Mancini FR; Mahamat-Saleh Y; Aleksandrova K; Kaaks R; Kühn T; Trichopoulou A; Karakatsani A; Panico S; Tumino R; Palli D; Tagliabue G; Naccarati A; Vermeulen RCH; Bueno-de-Mesquita HB; Weiderpass E; Skeie G; Ramón Quirós J; Ardanaz E; Mokoroa O; Sala N; Sánchez MJ; Huerta JM; Winkvist A; Harlid S; Ohlsson B; Sjöberg K; Schmidt JA; Wareham N; Khaw KT; Ferrari P; Rothwell JA; Gunter M; Riboli E; Scalbert A; Jenab M
    Int J Cancer; 2021 Feb; 148(3):609-625. PubMed ID: 32734650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A plasma metabolomic signature discloses human breast cancer.
    Jové M; Collado R; Quiles JL; Ramírez-Tortosa MC; Sol J; Ruiz-Sanjuan M; Fernandez M; de la Torre Cabrera C; Ramírez-Tortosa C; Granados-Principal S; Sánchez-Rovira P; Pamplona R
    Oncotarget; 2017 Mar; 8(12):19522-19533. PubMed ID: 28076849
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.